Although a drug is not subsidized, exceptions can be made for individual patients who are particularly seriously ill.

In Sweden, it is the Council for New Therapies, the NT Council, that decides which medicines it may include.

It will also be an advisory recommendation for the regions.

Hear Gerd Lärfars explain why drug costs are rising and what is being done to counteract this development.